Form 4: Hinge Health President Executes Stock Sale

Hinge Health President James Pursley sold 16,000 shares of Class A Common Stock via a pre-arranged 10b5-1 trading plan.

Summary

• James Pursley, President of Hinge Health, Inc., sold a total of 16,000 shares of Class A Common Stock on May 26, 2026.
• The sales were executed in three tranches at weighted average prices of $53.29, $54.29, and $55.16.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2025.
• Following these transactions, the reporting person retains beneficial ownership of 780,223 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned 10b5-1 program, which is a routine administrative action for corporate officers.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 trading plan, indicating the transaction was planned well in advance rather than based on non-public information.

Negatives

• The sale represents a reduction in the insider's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on current valuation.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard corporate governance practice for executives to manage personal liquidity and is generally not indicative of a change in company fundamentals.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives to avoid potential conflicts of interest regarding insider trading regulations.

Stakeholder Impact

• Minimal impact expected as the transaction was pre-planned and represents a small portion of the executive's total holdings.

Key Dates

Keywords

Hinge Health, HNGE, Insider Trading, Form 4, Stock Sale, James Pursley